Michael Pearson

Showing 5 posts of 5 posts found.

Former Valeant CEO Michael Pearson sues over $30m unpaid shares

March 28, 2017
Manufacturing and Production, Sales and Marketing Michael Pearson, Valeant

Ex-Valeant CEO Michael Pearson is suing his former company over its failure to deliver three million shares he claims he …

Valeant’s outgoing CEO subpoenaed by US congressional committee

March 29, 2016
Medical Communications, Research and Development Drug pricing, Michael Pearson, US, Valeant, committee, pearson, pharma, price hikes, senate aging committee, subpoena, subpoenaed

The US Senate Aging Committee has announced the issuing of a subpoena to the outgoing CEO of Valeant Pharmaceuticals, Michael …

Valeant CEO Pearson to leave company

March 21, 2016
Michael Pearson, Valeant

Valeant (NYSE:VRX) has announced that it has begun the search for a new CEO, confirming that Michael Pearson is to …

US Congress Committee pressures Valeant to produce drug pricing documents

March 11, 2016
Medical Communications, Sales and Marketing Drug pricing, Michael Pearson, Valeant

Valeant’s tough month continued yesterday, with a US congressional committee pressuring the company to explain why it has not produced …

Why 2016 could be a make or break year for Valeant

January 8, 2016
Medical Communications, Sales and Marketing Howard Schiller, J. Michael Pearson, Michael Pearson, Valeant

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

The Gateway to Local Adoption Series

Latest content